Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLC - Episode 7

Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023

January 5, 2024

Eduardo Santos, MD, FACP, FCCP, discusses recent advances in dual immunotherapy approaches for NSCLC, highlighting data from the CheckMate 9LA study.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Immunotherapy-Based Strategies for NSCLC in the Neoadjuvant/Perioperative Setting

EP. 2: Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023

EP. 3: Updates in Adjuvant Immunotherapy for NSCLC: Conference Highlights 2023

EP. 4: Immunotherapy-Based Treatment Strategies in Advanced NSCLC

EP. 5: EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC

EP. 6: Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials

Now Viewing

EP. 7: Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023

EP. 8: NSCLC 2023 Data Updates: Shaping the Future Treatment Landscape